StockNews.com downgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a report published on Wednesday. A number of other equities analysts also recently commented on AXGN. Canaccord Genuity Group restated a buy rating and issued a $11.00 price objective on shares of AxoGen in a report on […]
AxoGen, Inc (NASDAQ:AXGN) Sees Significant Growth in Short Interest themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com downgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a research report released on Saturday morning. Several other equities analysts have also issued reports on AXGN. SVB Leerink assumed coverage on shares of AxoGen in a report on Monday, October 16th. They set an outperform rating […]
StockNews.com lowered shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Saturday. AXGN has been the subject of several other research reports. Cantor Fitzgerald reiterated an overweight rating and set a $16.00 price target on shares of AxoGen in a research […]
ALACHUA and TAMPA, Fla., Jan. 04, 2024 Axogen, Inc. , a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that President and.